AXSM logo

Axsome Therapeutics (AXSM)

Profile

Full Name

Axsome Therapeutics, Inc.

Ticker Symbol

AXSM

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

November 19, 2015

Indexes

Not included

Website

http://www.axsome.com

Employees

683

Key Details

Price

$110.00

Market Cap

$5.36B(Mid cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$385.69M(+42.53% YoY)

Annual EPS

-$5.99(-13.66% YoY)

PE Ratio

-

Next earnings date

May 6, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$110.00
AXSM price is $110.00

Price All-time High

$138.70
AXSM price is currently -20.69% below its historical high of $138.70

Price Today Change

-0.72%
AXSM price is down -0.72% today

Price YTD Change

+30.01%
AXSM price is up +30.01% since January 1st

Price 1-year Change

+47.2%
AXSM price is up +47.2% year-on-year

Price 3-year Change

+150.51%
AXSM price is up +150.51% over the past 3 years

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market Cap

$5.36B
AXSM market capitalization is $5.36 billion

Market Cap 3-year Change

+214.18%
AXSM market capitalization is up +214.18% over the past 3 years

Market Cap All-time High

$6.76B
AXSM market capitalization is currently -20.69% below its historical high of $6.76 billion

Market Cap Sector Rank

89.42%
AXSM market capitalization is higher than 89.42% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+2.74%
AXSM shares outstanding is up +2.74% year-on-year

Shares Outstanding 3-Year Change

+25.41%
AXSM shares outstanding is up +25.41% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.76
AXSM beta is 0.76

200-day SMA

$96.32
AXSM price is currently +14.20% above its 200-day simple moving average

50-day SMA

$119.77
AXSM price is currently -8.16% below its 50-day simple moving average

RSI

36.05
AXSM 14-day relative strength index is 36.05

Volume

2.30
AXSM 30-day relative volume is 2.30

ATR

$5.22
AXSM average true range is $5.22

10-day Historical Volatility

45.30%
AXSM 10-day historical volatility is 45.30%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$385.69M
AXSM annual revenue is $385.69 million

Revenue Analysts Estimate

$622.13M
AXSM annual revenue is currently -38.00% lower than the consensus analysts' forecast

Revenue 1-year Change

+42.53%
AXSM annual revenue is up +42.53% year-on-year

Revenue Sector Rank

71.64%
AXSM annual revenue is higher than 71.64% of companies in Healthcare sector

EPS

EPS

-$5.99
AXSM annual earnings per share is -$5.99

EPS Analysts Estimate

-$3.42
AXSM annual earnings per share is currently +75.40% higher than the consensus analysts' forecast

EPS 1-year Change

-13.66%
AXSM annual earnings per share is down -13.66% year-on-year

EPS Sector Rank

17.14%
AXSM annual earnings per share is higher than 17.14% of companies in Healthcare sector

Profit

Gross Profit

$352.39M
AXSM annual gross profit is $352.39 million

Gross Margin

91.37%
AXSM annual gross profit margin is 91.37%

Operating Profit

-$252.44M
AXSM annual operating income is -$252.44 million

Operating Margin

-65.45%
AXSM annual operating profit margin is -65.45%

Net Income

-$287.22M
AXSM annual net profit is -$287.22 million

Net Margin

-74.47%
AXSM annual net profit margin is -74.47%

Expenses

Total Expenses

$638.13M
AXSM annual total expenses is $638.13 million

Operating Expenses

$604.83M
AXSM annual total operating expenses is $604.83 million

Cost Of Goods Sold

$33.30M
AXSM annual cost of goods sold is $33.30 million

Selling, General & Administrative Expenses

$411.36M
AXSM annual SGA is $411.36 million

Depreciation And Amortization

$7.96M
AXSM annual depreciation & amortization is $7.96 million

Interest Expense

$6.57M
AXSM annual interest expense is $6.57 million

Income Tax

$85.00K
AXSM annual income tax is $85.00 thousand

EBIT & EBITDA

EBIT

-$280.56M
AXSM annual earnings before interest & taxes is -$280.56 million

EBITDA

-$272.60M
AXSM annual EBITDA is -$272.60 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total Assets

$568.50M
AXSM annual total assets is $568.50 million

Non Current Assets

$83.43M
AXSM annual long term assets is $83.43 million

Current Assets

$485.06M
AXSM annual total current assets is $485.06 million

Cash And Cash Equivalents

$315.35M
AXSM annual cash & cash equivalents is $315.35 million

Accounts Receivable

$142.00M
AXSM annual accounts receivable is $142.00 million

Inventory

$15.73M
AXSM annual inventory is $15.73 million

Liabilities

Total Liabilities

$511.48M
AXSM annual total liabilities is $511.48 million

Long Term Liabilities

$281.38M
AXSM annual total long term liabilities is $281.38 million

Current Liabilities

$230.10M
AXSM annual total current liabilities is $230.10 million

Accounts Payable

$72.00M
AXSM annual accounts payable is $72.00 million

Debt

Total Debt

$192.96M
AXSM annual total debt is $192.96 million

Total Debt 1-year Change

+3.53%
AXSM annual total debt is up +3.53% year-on-year

Long Term Debt

$189.70M
AXSM annual long term debt is $189.70 million

Short Term Debt

$3.26M
AXSM annual short term debt is $3.26 million

Equity & Capital

Shareholders Equity

$57.02M
AXSM annual stockholders equity is $57.02 million

Book Value

$57.02M
AXSM annual book value is $57.02 million

Retained Earnings

-$1.12B
AXSM annual retained earnings is -$1.12 billion

Working Capital

$254.96M
AXSM annual working capital is $254.96 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash From Operations

-$128.41M
AXSM annual cash flow from operations is -$128.41 million

Cash From Operations 1-year Change

+11.49%
AXSM annual cash flow from operations is up +11.49% year-on-year

Cash From Investing

-$270.00K
AXSM annual cash flow from investing activities is -$270.00 thousand

Cash From Investing 1-year Change

+53.61%
AXSM annual cash flow from investing activities is up +53.61% year-on-year

Cash From Financing

$57.84M
AXSM annual cash flow from financing activities is $57.84 million

Cash From Financing 1-year Change

-82.53%
AXSM annual cash flow from financing activities is down -82.53% year-on-year

CAPEX

CAPEX

$270.00K
AXSM annual capital expenditures is $270.00 thousand

CAPEX 1-year Change

-53.61%
AXSM annual capital expenditures is down -53.61% year-on-year

Free Cash Flow

Free Cash Flow

-$128.68M
AXSM annual free cash flow is -$128.68 million

Free Cash Flow 1-year Change

+11.66%
AXSM annual free cash flow is up +11.66% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross Margin

91.37%
AXSM annual gross profit margin is 91.37%

Operating Margin

-65.45%
AXSM annual operating profit margin is -65.45%

Net Margin

-74.47%
AXSM annual net profit margin is -74.47%

ROA & ROE

ROA

-49.66%
AXSM annual return on assets is -49.66%

ROE

-231.63%
AXSM annual return on equity is -231.63%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

-
AXSM price to earnings ratio value is unknown

PE Ratio Sector Rank

-
AXSM price to earnings ratio is unknown

PB Ratio

PB Ratio

94.08
AXSM price to book ratio is 94.08

PB Ratio Sector Rank

99.18%
AXSM price to book ratio is higher than 99.18% of companies in Healthcare sector

PS Ratio

PS Ratio

13.91
AXSM price to sales ratio is 13.91

PS Ratio Sector Rank

83.25%
AXSM price to sales ratio is higher than 83.25% of companies in Healthcare sector

Enterprise value

Enterprise Value

$5.24B
AXSM enterprise value is $5.24 billion

Enterprise Value Sector Rank

88.37%
AXSM enterprise value is higher than 88.37% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-19.23
AXSM EV/EBITDA is -19.23

EV/EBITDA Sector Rank

6.91%
AXSM EV/EBITDA is higher than 6.91% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current Ratio

2.11
AXSM annual current ratio is 2.11

Quick Ratio

2.04
AXSM annual quick ratio is 2.04

Leverage

Debt To Equity

3.17
AXSM annual debt to equity ratio is 3.17

Interest Coverage Ratio

-42.71
AXSM annual interest coverage ratio is -42.71

Risk & Stability

Piotroski F-Score

3
AXSM piotroski f-score is 3

Altman Z-Score

3.12
AXSM altman z-score is 3.12

Analyst ratings

Recent major analysts updates

Apr 1, 25 Needham
Buy
Mar 27, 25 Mizuho
Outperform
Mar 6, 25 HC Wainwright & Co.
Buy
Mar 3, 25 Needham
Buy
Mar 3, 25 Baird
Outperform
Feb 27, 25 Morgan Stanley
Overweight
Feb 26, 25 Mizuho
Outperform
Feb 25, 25 HC Wainwright & Co.
Buy
Feb 24, 25 Needham
Buy
Feb 20, 25 HC Wainwright & Co.
Buy

Institutional Ownership

Similar stocks

Telix Pharmaceuticals Limited (TLX)
ELAN logo
Elanco Animal Health Incorporated (ELAN)
GKOS logo
Glaukos (GKOS)
BPMC logo
Blueprint Medicines (BPMC)
GH logo
Guardant Health (GH)
ALKS logo
Alkermes (ALKS)
KRYS logo
Krystal Biotech (KRYS)
STVN logo
Stevanato Group SpA (STVN)
BLCO logo
Bausch Lomb (BLCO)
  • What is the ticker symbol for Axsome Therapeutics?
  • Does Axsome Therapeutics pay dividends?
  • What sector is Axsome Therapeutics in?
  • What industry is Axsome Therapeutics in?
  • What country is Axsome Therapeutics based in?
  • When did Axsome Therapeutics go public?
  • Is Axsome Therapeutics in the S&P 500?
  • Is Axsome Therapeutics in the NASDAQ 100?
  • Is Axsome Therapeutics in the Dow Jones?
  • When was Axsome Therapeutics's last earnings report?
  • When does Axsome Therapeutics report earnings?
  • Should I buy Axsome Therapeutics stock now?

What is the ticker symbol for Axsome Therapeutics?

The ticker symbol for Axsome Therapeutics is NASDAQ:AXSM

Does Axsome Therapeutics pay dividends?

No, Axsome Therapeutics does not pay dividends

What sector is Axsome Therapeutics in?

Axsome Therapeutics is in the Healthcare sector

What industry is Axsome Therapeutics in?

Axsome Therapeutics is in the Biotechnology industry

What country is Axsome Therapeutics based in?

Axsome Therapeutics is headquartered in United States

When did Axsome Therapeutics go public?

Axsome Therapeutics's initial public offering (IPO) was on November 19, 2015

Is Axsome Therapeutics in the S&P 500?

No, Axsome Therapeutics is not included in the S&P 500 index

Is Axsome Therapeutics in the NASDAQ 100?

No, Axsome Therapeutics is not included in the NASDAQ 100 index

Is Axsome Therapeutics in the Dow Jones?

No, Axsome Therapeutics is not included in the Dow Jones index

When was Axsome Therapeutics's last earnings report?

Axsome Therapeutics's most recent earnings report was on Feb 18, 2025

When does Axsome Therapeutics report earnings?

The next expected earnings date for Axsome Therapeutics is May 6, 2025

Should I buy Axsome Therapeutics stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page